Fresenius SE & Co KGaA (FREG.DE) News| Reuters.com
Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

62.75EUR
28 Jun 2016
Change (% chg)

€0.81 (+1.31%)
Prev Close
€61.94
Open
€62.75
Day's High
€63.13
Day's Low
€62.34
Volume
211,727
Avg. Vol
1,190,246
52-wk High
€70.00
52-wk Low
€52.39

Select another date:

Mon, Jun 27 2016

Photo

Nestle poaches CEO from Fresenius in health and wellness drive

ZURICH Nestle SA named Ulf Mark Schneider as its next chief executive in a surprise choice on Monday, as the Swiss food giant underlined a shift towards health and wellness by poaching the boss of German healthcare group Fresenius .

UPDATE 2-Nestle poaches CEO from Fresenius in health and wellness drive

* Departing CEO Bulcke nominated as next Chairman (Adds details on Schneider throughout)

Nestle appoints Fresenius' Ulf Mark Schneider as CEO

ZURICH, June 27 Nestle SA poached Fresenius Chief Executive Ulf Mark Schneider to replace long-standing CEO Paul Bulcke, the Swiss food giant said on Monday.

UPDATE 1-Fresenius promotes CFO Sturm to CEO job after Schneider quits

BERLIN, June 26 German healthcare group Fresenius SE has appointed finance chief Stephan Sturm as its new chief executive to replace long-serving boss Ulf Mark Schneider, who quadrupled sales during his 13 years in charge.

Fresenius promotes CFO Sturm to CEO job after Schneider quits

BERLIN, June 26 German healthcare group Fresenius SE has appointed finance chief Stephan Sturm as its new chief executive, saying on Sunday that long-serving boss Ulf Mark Schneider is leaving to pursue other opportunities.

BRIEF-Stroeer says successfully refinanced

* Says Ströer optimizes its maturity structure and increases its financial flexibility through successful refinancing

BRIEF-Aurelius to rename company "AURELIUS Equity Opportunities SE & Co. KGaA".

* Resolution was agreed to rename company "AURELIUS Equity Opportunities SE & Co. KGaA". Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources

FRANKFURT, June 6 German healthcare supplier Fresenius and British engineering company Smiths Group have emerged as the final bidders for Pfizer's infusion pumps business in a possible deal worth close to $1.5 billion, people familiar with the matter said.

BRIEF-Fresenius SE says Loew-Friedrich, Stars to be appointed to board

* Says Roland Berger, Gerhard Roggemann to quit supervisory board

BRIEF-Fresenius says Gerd Krick to run again for supervisory board chairman

* If elected to the supervisory board, Gerd Krick will be proposed for election as chairman Further company coverage:

Select another date: